These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 4711169

  • 1. Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB.
    Reddy J, Svoboda D, Azarnoff D.
    Biochem Biophys Res Commun; 1973 May 15; 52(2):537-43. PubMed ID: 4711169
    [No Abstract] [Full Text] [Related]

  • 2. Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. Absence of sex difference in response.
    Reddy JK, Azarnoff DL, Svoboda DJ, Prasad JD.
    J Cell Biol; 1974 May 15; 61(2):344-58. PubMed ID: 4208071
    [Abstract] [Full Text] [Related]

  • 3. Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
    Moody DE, Reddy JK.
    Res Commun Chem Pathol Pharmacol; 1974 Nov 15; 9(3):501-10. PubMed ID: 4445568
    [No Abstract] [Full Text] [Related]

  • 4. Hepatic microbody proliferation and catalase synthesis induced by methyl clofenapate, a hypolipidemic analog of CPIB.
    Reddy JK.
    Am J Pathol; 1974 Apr 15; 75(1):103-18. PubMed ID: 4825610
    [Abstract] [Full Text] [Related]

  • 5. Possible properties of microbodies (peroxisomes). Microbody proliferation and hypolipidemic drugs.
    Reddy JK.
    J Histochem Cytochem; 1973 Nov 15; 21(11):967-71. PubMed ID: 4587529
    [No Abstract] [Full Text] [Related]

  • 6. The peroxisome proliferation-associated polypeptide in rat liver.
    Reddy JK, Kumar NS.
    Biochem Biophys Res Commun; 1977 Aug 08; 77(3):824-9. PubMed ID: 901515
    [No Abstract] [Full Text] [Related]

  • 7. Structure, composition, physical properties, and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liver.
    Leighton F, Coloma L, Koenig C.
    J Cell Biol; 1975 Nov 08; 67(2PT.1):281-309. PubMed ID: 406
    [Abstract] [Full Text] [Related]

  • 8. Proliferation of microbodies and synthesis of catalase in rat liver. Induction in tumor-bearing host by CPIB.
    Reddy J, Svoboda D.
    Am J Pathol; 1971 Apr 08; 63(1):99-108. PubMed ID: 4323477
    [No Abstract] [Full Text] [Related]

  • 9. Response of microperoxisomes in rat small intestinal mucosa to CPIB, a hypolipidemic drug.
    Svoboda DJ.
    Biochem Pharmacol; 1976 Dec 15; 25(24):2750-2. PubMed ID: 1008899
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate.
    Reddy JK, Krishnakantha TP.
    Science; 1975 Nov 21; 190(4216):787-9. PubMed ID: 1198095
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of hypolipidemic drugs, nafenopin and clofibrate, on the concentration of ligandin and Z protein in rat liver.
    Fleischner G, Meijer DK, Levine WG, Gatmaitan Z, Gluck R, Arias IM.
    Biochem Biophys Res Commun; 1975 Dec 15; 67(4):1401-7. PubMed ID: 812503
    [No Abstract] [Full Text] [Related]

  • 15. Clofibrate and nafenopin (SU-13437): effects on plasma clearance and tissue distribution of chylomicron triglyceride in the dog.
    Cenedella RJ.
    Lipids; 1972 Oct 15; 7(10):644-52. PubMed ID: 4635558
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hepatic effect of two hypolipidemic drugs in rats.
    Magnusson G, Magnusson O.
    Exp Pathol (Jena); 1977 Oct 15; 13(2-3):180-7. PubMed ID: 913535
    [Abstract] [Full Text] [Related]

  • 20. Prevention of CeCl3-induced hepatotoxicity by hypolipidemic compounds.
    Tuchweber B, Salas M.
    Arch Toxicol; 1978 Dec 28; 41(3):223-32. PubMed ID: 736793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.